In Vitro Antifungal Activity of Azoles and Other Antifungal Agents Against Pathogenic Yeasts from Vulvovaginal Candidiasis in China.

Siyue KanNana SongQiuyu PangHuan MeiHailin ZhengDongmei LiFan CuiGuixia LvRuifang AnPing LiZhengai XiongShangrong FanMengzhen ZhangYanhong ChenQiao QiaoXudong LiangManhua CuiDongyan LiQinping LiaoXiaofang LiWeida Liu

Published in: Mycopathologia (2022)

C. albicans was still the predominant pathogen for VVC in China, while C. glabrata was the main species in NAC. Fluconazole could still be used as an empirical treatment for uncomplicated VVC. However, fluconazole may not be the first choice for the therapy of RVVC. In such cases, itraconazole appears to be the more appropriate treatment. As for VVC caused by NAC, nonfluconazole drugs, such as itraconazole, may be a good choice.

Keyphrases

candida albicans
transcription factor
stem cells
combination therapy
replacement therapy
decision making
urinary tract infection
smoking cessation